I would like to tell you a story I have read many times. It is an old story, written very long ago, a story that everyone should know. 947 more words
Tags » Chronic Lymphocytic Leukemia
The FDA announces on July 23rd, that Gilead Sciences’ drug, Zydelig (Idelalisib), receives 3 approvals for blood cancers.
The 1st FDA approval is the “traditional approval” of Gilead Sciences’ FDA Breakthrough Therapy (BTD) Designated product, Zydelig, for relapsed Chronic Lymphocytic Leukemia (CLL). 310 more words
Earlier this afternoon the FDA announced the approval of Zydelig (idelalisib) for patients with relapsed chronic lymphocytic leukemia (CLL). Accelerated approval was also granted for the use of Zydelig in patients with relapsed follicular B-cell non-Hodgkin lymphoma (FL) and relapsed small lymphocytic lymphoma (SLL). 239 more words
Dean Martin had it at least partially correct; we’re goin’ back to Houston, but not because it is gettin’ lonely in this old town. We will leave all of our friends behind and go to the big city because that is where the healin’ is. 506 more words